Literature DB >> 7800942

Detection of HIV DNA in peripheral blood dendritic cells of HIV-infected individuals.

S Patterson1, M S Roberts, N R English, S E Macatonia, M N Gompels, A J Pinching, S C Knight.   

Abstract

Previous studies from this laboratory indicated infection of dendritic cells (DC) from peripheral blood of individuals infected with HIV1. Here, further evidence for the infection of peripheral blood DC with HIV1 is presented. Low-density cells (LDC) were prepared from blood mononuclear cells of HIV-infected individuals at different clinical stages of disease. These cells are enriched (10-40%) for MHC class-II-bearing DC, while most of the remaining cells are monocytes, and 2-10% are lymphocytes. A quantitative polymerase chain technique (PCR) was used to estimate the HIV provirus load in LDC and lymphocytes of patients in different disease categories. HIV provirus was detected in every LDC preparation, and for many individuals, particularly CDC stage IV patients, the load was higher in the LDC than in the lymphocyte fraction. These findings suggested that patient DC are infected with HIV. In order to provide confirmatory evidence for this conclusion, PCR was performed on DC that were highly purified from LDC by panning to remove contaminating T, B, natural killer and monocytic cells. High levels of HIV provirus were found in these purified DC. These findings suggest that DC provide a reservoir of HIV and that the consequences of such infection may be relevant to the development of disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800942     DOI: 10.1016/s0923-2516(07)80019-7

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  9 in total

1.  Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Authors:  M T Dittmar; G Simmons; S Hibbitts; M O'Hare; S Louisirirotchanakul; S Beddows; J Weber; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.

Authors:  M Gompels; S Patterson; M S Roberts; S E Macatonia; A J Pinching; S C Knight
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

3.  Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

Authors:  M T Dittmar; G Simmons; Y Donaldson; P Simmonds; P R Clapham; T F Schulz; R A Weiss
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 4.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.

Authors:  J Cao; I W Park; A Cooper; J Sodroski
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Complementary antiviral efficacy of hydroxyurea and protease inhibitors in human immunodeficiency virus-infected dendritic cells and lymphocytes.

Authors:  Giampiero Piccinini; Andrea Foli; Giuditta Comolli; Julianna Lisziewicz; Franco Lori
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.

Authors:  S S Frankel; R M Steinman; N L Michael; S R Kim; N Bhardwaj; M Pope; M K Louder; P K Ehrenberg; P W Parren; D R Burton; H Katinger; T C VanCott; M L Robb; D L Birx; J R Mascola
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Methamphetamine modulates DC-SIGN expression by mature dendritic cells.

Authors:  Madhavan P N Nair; Supriya Mahajan; Don Sykes; Meghana V Bapardekar; Jessica L Reynolds
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-23       Impact factor: 4.147

Review 9.  Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells.

Authors:  Elisabeth Littwitz-Salomon; Ulf Dittmer; Kathrin Sutter
Journal:  Retrovirology       Date:  2016-11-08       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.